Immunocore Holdings (IMCR) Current Leases (2019 - 2026)

Immunocore Holdings has disclosed Current Leases across 8 years of filings, most recently posting $2.0 million for Q1 2026.

• Current Leases for Q1 2026 came in at $2.0 million, up 16.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 16.25% YoY), and the FY2025 annual result was $2.0 million, up 29.67% from the prior year.
• Current Leases came in at $2.0 million for Q1 2026 at Immunocore Holdings, roughly flat from $2.0 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.0 million in Q4 2025 to a low of $1.1 million in Q3 2024.
• The 5-year median for Current Leases is $1.7 million (2025), against an average of $1.6 million.
• Across the five-year window, Current Leases declined 23.9% in 2023 and surged 71.19% in 2025, its largest moves.
• Immunocore Holdings' Current Leases stood at $1.8 million in 2022, then decreased by 23.9% to $1.4 million in 2023, then advanced by 11.46% to $1.5 million in 2024, then gained by 29.67% to $2.0 million in 2025, then retreated by 0.5% to $2.0 million in 2026.
• The last three Current Leases figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.